A new study has found that semaglutide—better known as the weight loss injection Wegovy or Ozempic—might do more than help people shed extra pounds. Early research suggests that it could also reduce cravings for alcohol and cut down how much...
In a groundbreaking real-world study, Eli Lilly's Mounjaro (tirzepatide) demonstrated superior weight loss compared to Novo Nordisk's Ozempic (semaglutide), both of which are popular drugs for treating type 2 diabetes and obesity. This study, published in JAMA Internal Medicine, marks...
GLP-1 (glucagon-like peptide-1) receptor agonists have gained popularity as effective medications for weight management and type 2 diabetes treatment. These drugs, such as semaglutide (Ozempic/Wegovy) and Mounjaro, work by enhancing insulin secretion, reducing appetite, and slowing gastric emptying. However, as...
